“Nonaddictive” pain pill could win FDA approval

If successful, the Vertex drug suzetrigine would offer an alternative to potent prescription painkillers such as oxycodone, which was once heavily marketed by drug companies and fuelled an epidemic of dependency and death. The company’s application is pending before the FDA, and could be approved by the end of January.